Lack of cross-reactivity between cefotaxime and imipenem. 2006

K Aouam, and F Ben Romdhane, and C Loussaief, and M Chakroun, and N A Boughattas, and N Bouzouaia

UI MeSH Term Description Entries
D008297 Male Males
D002439 Cefotaxime Semisynthetic broad-spectrum cephalosporin. Benaxima,Biosint,Cefotaxim,Cefotaxime Sodium,Cefradil,Cephotaxim,Claforan,Fotexina,HR-756,Kendrick,Klaforan,Primafen,Ru-24756,Taporin,HR 756,HR756,Ru 24756,Ru24756,Sodium, Cefotaxime
D005076 Exanthema Diseases in which skin eruptions or rashes are a prominent manifestation. Classically, six such diseases were described with similar rashes; they were numbered in the order in which they were reported. Only the fourth (Duke's disease), fifth (ERYTHEMA INFECTIOSUM), and sixth (EXANTHEMA SUBITUM) numeric designations survive as occasional synonyms in current terminology. Rash,Skin Rash,Exanthem,Rash, Skin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013557 Switzerland A country in Europe. It is bordered by Austria, France, Italy, Liechtenstein, and Germany. The capital is Bern.
D015378 Imipenem Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor. Imipemide,N-Formimidoylthienamycin,Imipenem Anhydrous,Imipenem, Anhydrous,MK-0787,MK0787,Anhydrous Imipenem,Anhydrous, Imipenem,MK 0787,N Formimidoylthienamycin

Related Publications

K Aouam, and F Ben Romdhane, and C Loussaief, and M Chakroun, and N A Boughattas, and N Bouzouaia
July 1990, Thrombosis research,
K Aouam, and F Ben Romdhane, and C Loussaief, and M Chakroun, and N A Boughattas, and N Bouzouaia
April 2009, Antimicrobial agents and chemotherapy,
K Aouam, and F Ben Romdhane, and C Loussaief, and M Chakroun, and N A Boughattas, and N Bouzouaia
January 2004, The Journal of allergy and clinical immunology,
K Aouam, and F Ben Romdhane, and C Loussaief, and M Chakroun, and N A Boughattas, and N Bouzouaia
August 1988, The Journal of allergy and clinical immunology,
K Aouam, and F Ben Romdhane, and C Loussaief, and M Chakroun, and N A Boughattas, and N Bouzouaia
June 1987, European journal of clinical microbiology,
K Aouam, and F Ben Romdhane, and C Loussaief, and M Chakroun, and N A Boughattas, and N Bouzouaia
January 1987, Clinical allergy,
K Aouam, and F Ben Romdhane, and C Loussaief, and M Chakroun, and N A Boughattas, and N Bouzouaia
August 1989, The American journal of the medical sciences,
K Aouam, and F Ben Romdhane, and C Loussaief, and M Chakroun, and N A Boughattas, and N Bouzouaia
September 1984, The Tohoku journal of experimental medicine,
K Aouam, and F Ben Romdhane, and C Loussaief, and M Chakroun, and N A Boughattas, and N Bouzouaia
January 1983, Therapeutic drug monitoring,
K Aouam, and F Ben Romdhane, and C Loussaief, and M Chakroun, and N A Boughattas, and N Bouzouaia
October 1998, International archives of allergy and immunology,
Copied contents to your clipboard!